{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:17:37Z","timestamp":1788880657666,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41443-024-00845-2","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T20:03:20Z","timestamp":1709841800000},"page":"801-808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unveiling the molecular Hallmarks of Peyronie\u2019s disease: a comprehensive narrative review"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3139-8205","authenticated-orcid":false,"given":"Ali","family":"\u015eahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyn","family":"Babayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-4272","authenticated-orcid":false,"given":"Lorenzo","family":"Cirigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8144-6498","authenticated-orcid":false,"given":"Mirko","family":"Preto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1101-892X","authenticated-orcid":false,"given":"Marco","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6797-3937","authenticated-orcid":false,"given":"Emre","family":"Alt\u0131ntas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-6227","authenticated-orcid":false,"given":"Murat","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"845_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jsxm.2016.04.062","volume":"13","author":"E Chung","year":"2016","unstructured":"Chung E, Ralph D, Kagioglu A, et al. Evidence-based management guidelines on Peyronie\u2019s disease. J Sex Med. 2016;13:905\u201323.","journal-title":"J Sex Med"},{"key":"845_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00345-019-02815-6","volume":"38","author":"DP Patel","year":"2020","unstructured":"Patel DP, Christensen MB, Hotaling JM, Pastuszak AW. A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie\u2019s disease. World J Urol. 2020;38:253\u201361.","journal-title":"World J Urol"},{"key":"845_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11930-015-0045-y","volume":"7","author":"AN Bilgutay","year":"2015","unstructured":"Bilgutay AN, Pastuszak AW. Peyronie\u2019s disease: a review of etiology, diagnosis, and management. Curr Sex Health Rep. 2015;7:117\u201331.","journal-title":"Curr Sex Health Rep"},{"key":"845_CR4","first-page":"139","volume":"13","author":"FE Kuehhas","year":"2011","unstructured":"Kuehhas FE, Weibl P, Georgi T, Djakovic N, Herwig R. Peyronie\u2019s disease: nonsurgical therapy options. Rev Urol. 2011;13:139\u201346.","journal-title":"Rev Urol"},{"key":"845_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and smad-independent pathways in TGF-\u03b2 family signalling. Nature. 2003;425:577\u201384.","journal-title":"Nature"},{"key":"845_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrneph.2014.184","volume":"10","author":"HM Kok","year":"2014","unstructured":"Kok HM, Falke LL, Goldschmeding R, Nguyen TQ. Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. Nat Rev Nephrol. 2014;10:700\u201311.","journal-title":"Nat Rev Nephrol"},{"key":"845_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1046\/j.1523-1755.2001.059002579.x","volume":"59","author":"F Strutz","year":"2001","unstructured":"Strutz F, Zeisberg M, Renziehausen A, Raschke B, Becker V, van Kooten C, et al. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int. 2001;59:579\u201392. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.059002579.x.","journal-title":"Kidney Int"},{"key":"845_CR8","doi-asserted-by":"publisher","first-page":"BSR20190756","DOI":"10.1042\/BSR20190756","volume":"40","author":"CM Weng","year":"2020","unstructured":"Weng CM, Li Q, Chen KJ, Xu CX, Deng MS, Li T, et al. Bleomycin induces epithelial-to-mesenchymal transition via bFGF\/PI3K\/ESRP1 signaling in pulmonary fibrosis. Biosci Rep. 2020;40:BSR20190756 https:\/\/doi.org\/10.1042\/BSR20190756.","journal-title":"Biosci Rep"},{"key":"845_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.617671","volume":"12","author":"F Maccarinelli","year":"2021","unstructured":"Maccarinelli F, Bugatti M, Churruca Schuind A, Ganzerla S, Vermi W, Presta M, et al. Endogenous long Pentraxin 3 exerts a protective role in a murine model of pulmonary fibrosis. Front Immunol. 2021;12:617671 https:\/\/doi.org\/10.3389\/fimmu.2021.617671.","journal-title":"Front Immunol"},{"key":"845_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","volume":"68","author":"E Roeb","year":"2018","unstructured":"Roeb E. Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol. 2018;68:463\u201373.","journal-title":"Matrix Biol"},{"key":"845_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2014.00123","volume":"5","author":"RT Kendall","year":"2014","unstructured":"Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:123.","journal-title":"Front Pharmacol"},{"key":"845_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-11-233","volume":"12","author":"G Murphy","year":"2011","unstructured":"Murphy G. Tissue inhibitors of metalloproteinases. Genome Biol. 2011;12:233 https:\/\/doi.org\/10.1186\/gb-2011-12-11-233.","journal-title":"Genome Biol"},{"key":"845_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"845_CR14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"RJ Akhurst","year":"2012","unstructured":"Akhurst RJ, Hata A. Targeting the TGF\u03b2 signalling pathway in disease. Nat Rev Drug Discov. 2012;11:790\u2013811.","journal-title":"Nat Rev Drug Discov"},{"key":"845_CR15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/nrm2297","volume":"8","author":"B Schmierer","year":"2007","unstructured":"Schmierer B, Hill CS. TGF\u03b2\u2013SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol. 2007;8:970\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"845_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","volume":"134","author":"MO Li","year":"2008","unstructured":"Li MO, Flavell RA. TGF-\u03b2: a master of all T cell trades. Cell. 2008;134:392\u2013404.","journal-title":"Cell"},{"key":"845_CR17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","volume":"158","author":"AI El-Sakka","year":"1997","unstructured":"El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF. Peyronie\u2019s disease is associated with an increase in transforming growth factor-beta protein expression. J Urol. 1997;158:1391\u20134.","journal-title":"J Urol"},{"key":"845_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.eururo.2006.05.002","volume":"51","author":"SM Haag","year":"2007","unstructured":"Haag SM, Hauck EW, Szardening-Kirchner C, Diemer T, Cha ES, Weidner W, et al. Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie\u2019s disease. Eur Urol. 2007;51:255\u201361. https:\/\/doi.org\/10.1016\/j.eururo.2006.05.002.","journal-title":"Eur Urol"},{"key":"845_CR19","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1097\/01.asn.0000014252.37680.e4","volume":"13","author":"JH Li","year":"2002","unstructured":"Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol. 2002;13:1464\u201372. https:\/\/doi.org\/10.1097\/01.asn.0000014252.37680.e4.","journal-title":"J Am Soc Nephrol"},{"key":"845_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0090-4295(01)01578-3","volume":"59","author":"TR Magee","year":"2002","unstructured":"Magee TR, Qian A, Rajfer J, Sander FC, Levine LA, Gonzalez-Cadavid NF. Gene expression profiles in the Peyronie\u2019s disease plaque. Urology. 2002;59:451\u20137.","journal-title":"Urology"},{"key":"845_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0022-5347(05)64129-8","volume":"169","author":"EW Hauck","year":"2003","unstructured":"Hauck EW, Hauptmann A, Schmelz HU, Bein G, Weidner W, Hackstein H. Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie\u2019s disease. J Urol. 2003;169:369\u201372. https:\/\/doi.org\/10.1016\/S0022-5347(05)64129-8.","journal-title":"J Urol"},{"key":"845_CR22","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3892\/ijo.2013.1905","volume":"42","author":"KH Jung","year":"2013","unstructured":"Jung KH, Ryu YL, Lee HS, Lee H, Son MK, Yan HH, et al. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie\u2019s plaques. Int J Oncol. 2013;42:2001\u20138.","journal-title":"Int J Oncol"},{"key":"845_CR23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.5534\/wjmh.190071","volume":"38","author":"KM Song","year":"2020","unstructured":"Song KM, Chung DY, Choi MJ, Ghatak K, Minh NN, Limanjaya A, et al. Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, promotes regression of fibrotic plaques in a rat model of Peyronie\u2019s disease. World J Men\u2019s Health. 2020;38:552\u201363. https:\/\/doi.org\/10.5534\/wjmh.190071.","journal-title":"World J Men\u2019s Health"},{"key":"845_CR24","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1002\/jcp.25049","volume":"230","author":"JM Carthy","year":"2015","unstructured":"Carthy JM, Sundqvist A, Heldin A, van Dam H, Kletsas D, Heldin CH, et al. Tamoxifen inhibits TGF-\u03b2-Mediated activation of myofibroblasts by blocking non-smad signaling through ERK1\/2. J Cell. Physiol. 2015;230:3084\u201392. https:\/\/doi.org\/10.1002\/jcp.25049.","journal-title":"J Cell. Physiol"},{"key":"845_CR25","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","volume":"162","author":"C Teloken","year":"1999","unstructured":"Teloken C, Rhoden EL, Grazziotin TM, Ros CT, Sogari PR, Souto CA. Tamoxifen versus placebo in the treatment of Peyronie\u2019s disease. J Urol. 1999;162:2003\u20135. https:\/\/doi.org\/10.1016\/S0022-5347(05)68087-1.","journal-title":"J Urol"},{"key":"845_CR26","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/j.1743-6109.2010.01790.x","volume":"7","author":"AW Shindel","year":"2010","unstructured":"Shindel AW, Lin G, Ning H, Banie L, Huang YC, Liu G, et al. Pentoxifylline attenuates transforming growth factor-\u03b21-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix. J Sex Med. 2010;7:2077\u201385. https:\/\/doi.org\/10.1111\/j.1743-6109.2010.01790.x.","journal-title":"J Sex Med"},{"key":"845_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/aja.2010.117","volume":"13","author":"JF Smith","year":"2011","unstructured":"Smith JF, Shindel AW, Huang YC, Clavijo RI, Flechner L, Breyer BN, et al. Pentoxifylline treatment and penile calcifications in men with Peyronie\u2019s disease. Asian J Androl. 2011;13:322\u20135. https:\/\/doi.org\/10.1038\/aja.2010.117.","journal-title":"Asian J Androl"},{"key":"845_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2017.83","volume":"13","author":"S Rose-John","year":"2017","unstructured":"Rose-John S, Winthrop K, Calabrese L.The role of IL-6 in host defence against infections: immunobiology and clinical implications.Nat Rev Rheumatol. 2017;13:399\u2013409.","journal-title":"Nat Rev Rheumatol"},{"key":"845_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrrheum.2014.127","volume":"10","author":"LH Calabrese","year":"2014","unstructured":"Calabrese LH, Rose-John S.IL-6 biology: implications for clinical targeting in rheumatic disease.Nat Rev Rheumatol. 2014;10:720\u20137.","journal-title":"Nat Rev Rheumatol"},{"key":"845_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1165\/rcmb.2002-0262OC","volume":"29","author":"YP Moodley","year":"2003","unstructured":"Moodley YP, Misso NL, Scaffidi AK, Fogel-Petrovic M, McAnulty RJ, Laurent GJ, et al. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol. 2003;29:490\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"845_CR31","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1136\/annrheumdis-2018-213031","volume":"77","author":"CP Denton","year":"2018","unstructured":"Denton CP, Ong VH, Xu S, Chen-Harris H, Modrusan Z, Lafyatis R, et al. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. Annal Rheum Dis. 2018;77:1362\u201371.","journal-title":"Annal Rheum Dis"},{"key":"845_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.kjms.2017.01.007","volume":"33","author":"Arda Atar","year":"2017","unstructured":"Atar Arda, et al. Role of interleukin-6 and pentraxin 3 as an early marker in Peyronie\u2019s disease. Kaohsiung J Med Sci. 2017;33:195\u2013200.","journal-title":"Kaohsiung J Med Sci"},{"key":"845_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jare.2017.06.004","volume":"8","author":"MS Watanabe","year":"2017","unstructured":"Watanabe MS, Theodoro TR, Coelho NL, Mendes A, Leonel MLP, Mader AM, et al. Extracellular matrix alterations in the Peyronie\u2019s disease. J Adv Res. 2017;8:455\u201361.","journal-title":"J Adv Res"},{"key":"845_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1590\/S1677-55382008000400008","volume":"34","author":"RP Zimmermann","year":"2008","unstructured":"Zimmermann RP, Feil G, Bock C, Hoeltl L, Stenzl A. Significant alterations of serum cytokine levels in patients with Peyronie\u2019s disease. Int. braz J Urol. 2008;34:457\u201366.","journal-title":"Int. braz J Urol"},{"key":"845_CR35","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","volume":"28","author":"M Cesari","year":"2010","unstructured":"Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28:e72\u201391. https:\/\/doi.org\/10.1111\/j.1755-5922.2010.00171.x.","journal-title":"Cardiovasc Ther"},{"key":"845_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrneph.2009.15","volume":"5","author":"H Ha","year":"2009","unstructured":"Ha H, Oh EY, Lee HB. The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. Nat Rev Nephrol. 2009;5:203\u201311. https:\/\/doi.org\/10.1038\/nrneph.2009.15.","journal-title":"Nat Rev Nephrol"},{"key":"845_CR37","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1046\/j.1464-410X.2003.04224.x","volume":"91","author":"HH Davila","year":"2003","unstructured":"Davila HH, et al. Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie\u2019s disease.\u201d. BJU Int. 2003;91:830\u20138.","journal-title":"BJU Int"},{"key":"845_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.urology.2005.01.010","volume":"65","author":"HugoH Davila","year":"2005","unstructured":"Davila HugoH, et al. \u201cPeyronie\u2019s disease associated with increase in plasminogen activator inhibitor in fibrotic plaque.\u201d. Urology. 2005;65:645\u20138.","journal-title":"Urology"},{"key":"845_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1152\/physrev.00016.2017","volume":"98","author":"C Garlanda","year":"2018","unstructured":"Garlanda C, Bottazzi B, Magrini E, Inforzato A, Mantovani A. PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer. Physiol Rev. 2018;98:623\u201339. https:\/\/doi.org\/10.1152\/physrev.00016.2017.","journal-title":"Physiol Rev"},{"key":"845_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2639248","volume":"2019","author":"J Gorka-Dynysiewicz","year":"2019","unstructured":"Gorka-Dynysiewicz J, Pazgan-Simon M, Zuwala-Jagiello J. Pentraxin 3 detects clinically significant fibrosis in patients with chronic viral hepatitis C. BioMed Res Int. 2019;2019:2639248 https:\/\/doi.org\/10.1155\/2019\/2639248.","journal-title":"BioMed Res Int"},{"key":"845_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-16610-z","volume":"7","author":"SB Mamer","year":"2017","unstructured":"Mamer SB, Chen S, Weddell JC, Palasz A, Wittenkeller A, Kumar M, et al. Discovery of high-affinity PDGF-VEGFR interactions: redefining RTK dynamics. Sci Rep. 2017;7:1\u201314.","journal-title":"Sci Rep"},{"key":"845_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ijbiomac.2022.01.113","volume":"202","author":"X Zou","year":"2022","unstructured":"Zou X, Tang XY, Qu ZY, Sun ZW, Ji CF, Li YJ, et al. Targeting the PDGF\/PDGFR signaling pathway for cancer therapy: a review. Int J Biol Macromol. 2022;202:539\u201357.","journal-title":"Int J Biol Macromol"},{"key":"845_CR43","doi-asserted-by":"publisher","first-page":"H1719","DOI":"10.1152\/ajpheart.00130.2013","volume":"304","author":"Tieqiang Zhao","year":"2013","unstructured":"Zhao Tieqiang, et al. \u201cPlatelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts.\u201d. Am J Physiol-Heart Circ Physiol. 2013;304:H1719\u201326.","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"845_CR44","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.biocel.2008.05.012","volume":"40","author":"M Lucattelli","year":"2008","unstructured":"Lucattelli M, Lunghi B, Fineschi S, Mirone V, di Villa Bianca RDE, Longo N, et al. A new mouse model of Peyronie\u2019s disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes. Int J Biochem Cell Biol. 2008;40:2638\u201348.","journal-title":"Int J Biochem Cell Biol"},{"key":"845_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/j.1939-4640.1996.tb01757.x","volume":"17","author":"V Gentile","year":"1996","unstructured":"Gentile V, et al. \u201cUltrastructural and immunohistochemlcal Characterization of the Tunica Albuginea in Peyronie\u2019s Disease and Veno\u2010occlusive Dysfunction.\u201d. J Androl. 1996;17:96\u2013103.","journal-title":"J Androl"},{"key":"845_CR46","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1677\/joe.0.1700395","volume":"170","author":"A Aversa","year":"2001","unstructured":"Aversa A, et al. \u201cPlatelet-derived growth factor (PDGF) and PDGF receptors in rat corpus cavernosum: changes in expression after transient in vivo hypoxia.\u201d. J Endocrinol. 2001;170:395\u2013402.","journal-title":"J Endocrinol"},{"key":"845_CR47","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827\u201339.","journal-title":"Circ Res"},{"key":"845_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.2047-2927.2013.00181.x","volume":"2","author":"A Gokce","year":"2014","unstructured":"Gokce A, Abd Elmageed ZY, Lasker GF, Bouljihad M, Kim H, Trost LW, et al. Adipose tissue\u2013derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie\u2019s disease. Andrology. 2014;2:244\u201351.","journal-title":"Andrology"},{"key":"845_CR49","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.jsxm.2016.02.024","volume":"13","author":"J Campbell","year":"2016","unstructured":"Campbell J, DeYoung L, Chung E, Brock G. 022 matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the pathogenesis of Peyronie\u2019s Disease. J Sex Med. 2016;13:S11.","journal-title":"J Sex Med"},{"key":"845_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.esxm.2018.09.003","volume":"7","author":"F Castiglione","year":"2019","unstructured":"Castiglione F, Hedlund P, Weyne E, Hakim L, Montorsi F, Bivalacqua TJ, et al. Intratunical injection of human adipose tissue\u2013derived stem cells restores collagen III\/I ratio in a rat model of chronic Peyronie\u2019s disease. Sex Med. 2019;7:94\u2013103.","journal-title":"Sex Med"},{"key":"845_CR51","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/j.juro.2008.01.093","volume":"179","author":"M Del Carlo","year":"2008","unstructured":"Del Carlo M, Cole AA, Levine LA. Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1\u03b2 and transforming growth factor-\u03b2 in Peyronie\u2019s plaque fibroblasts. J Urol. 2008;179:2447\u201355.","journal-title":"J Urol"},{"key":"845_CR52","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1111\/j.1743-6109.2010.01915.x","volume":"7","author":"Markos Karavitakis","year":"2010","unstructured":"Karavitakis Markos, et al. \u201cThe relationship between androgens, regulators of collagen metabolism, and Peyronie\u2019s disease: a case control study.\u201d. J Sex Med. 2010;7:4011\u20137.","journal-title":"J Sex Med"},{"key":"845_CR53","doi-asserted-by":"publisher","first-page":"e13831","DOI":"10.1111\/and.13831","volume":"52","author":"Q Yang","year":"2020","unstructured":"Yang Q, Chen W, Han D, Zhang C, Xie Y, Sun X, et al. Intratunical injection of human urine\u2010derived stem cells derived exosomes prevents fibrosis and improves erectile function in a rat model of Peyronie\u2019s disease. Andrologia. 2020;52:e13831.","journal-title":"Andrologia"},{"key":"845_CR54","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21:268\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"845_CR55","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jcmgh.2015.09.005","volume":"1","author":"KJ Roth","year":"2015","unstructured":"Roth KJ, Copple BL. Role of hypoxia-inducible factors in the development of liver fibrosis. Cell Mol Gastroenterol Hepatol. 2015;1:589\u201397.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"845_CR56","doi-asserted-by":"publisher","first-page":"155798832211117","DOI":"10.1177\/15579883221111720","volume":"16","author":"Y Cui","year":"2022","unstructured":"Cui Y, Wang Y, Men C, Wu J, Liu L. Bioinformatics-Based identification of potential hypoxia-related genes associated with Peyronie\u2019s Disease. Am J Men\u2019s Health. 2022;16:15579883221111720.","journal-title":"Am J Men\u2019s Health"},{"key":"845_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15972-8","volume":"7","author":"J Hu","year":"2017","unstructured":"Hu J, Wang W, Zhang F, Li PL, Boini KM, Yi F, et al. Hypoxia inducible factor-1\u03b1 mediates the profibrotic effect of albumin in renal tubular cells. Sci Rep. 2017;7:15878.","journal-title":"Sci Rep"},{"key":"845_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5152\/eurjrheum.2020.20101","volume":"8","author":"M Solakhan","year":"2021","unstructured":"Solakhan M, K\u0131sac\u0131k B. Is Peyronie\u2019s an IgG4-related disease? Eur J Rheumatol. 2021;8:27.","journal-title":"Eur J Rheumatol"},{"key":"845_CR59","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","volume":"16","author":"CA Perugino","year":"2020","unstructured":"Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16:702\u201314.","journal-title":"Nat Rev Rheumatol"},{"key":"845_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","volume":"12","author":"GD Kalliolias","year":"2016","unstructured":"Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12:49\u201362.","journal-title":"Nat Rev Rheumatol"},{"key":"845_CR61","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.esxm.2017.06.001","volume":"5","author":"AW Shindel","year":"2017","unstructured":"Shindel AW, Sweet G, Thieu W, Durbin-Johnson B, Rothschild J, Szabo R. Prevalence of Peyronie\u2019s disease-Like symptoms in men presenting with Dupuytren contractures. Sex Med. 2017;5:e135\u201341.","journal-title":"Sex Med"},{"key":"845_CR62","doi-asserted-by":"publisher","first-page":"36099","DOI":"10.1074\/jbc.M505291200","volume":"280","author":"AL Theiss","year":"2005","unstructured":"Theiss AL, Simmons JG, Jobin C, Lund PK. Tumor necrosis factor (TNF) \u03b1 increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem. 2005;280:36099\u2013109.","journal-title":"J Biol Chem"},{"key":"845_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02864-1","volume":"11","author":"S Taguchi","year":"2021","unstructured":"Taguchi S, Azushima K, Yamaji T, Urate S, Suzuki T, Abe E, et al. Effects of tumor necrosis factor-\u03b1 inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy. Sci Rep. 2021;11:23587.","journal-title":"Sci Rep"},{"key":"845_CR64","doi-asserted-by":"publisher","first-page":"e1245","DOI":"10.1016\/S1569-9056(19)30893-0","volume":"18","author":"U Milenkovic","year":"2019","unstructured":"Milenkovic U, Janky R, Hatzichristodoulou G, Van Renterghem K, Cellek S, Bivalacqua TJ, et al. Transcriptome-wide analysis of Peyronie\u2019s disease plaques using RNA sequencing uncovers targetable signalling pathways for medical therapy. Eur Urol Suppl. 2019;18:e1245.","journal-title":"Eur Urol Suppl"},{"key":"845_CR65","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5301\/RU.2012.9686","volume":"79","author":"C Pavone","year":"2012","unstructured":"Pavone C, Caruana G, Abbadessa D, Scaduto G, Gambino G, Serretta V, et al. Cytokine gene expression in the tunica albuginea of patients with Peyronie\u2019s disease. Pilot study with a control group. Urol J. 2012;79:189\u201396.","journal-title":"Urol J"},{"key":"845_CR66","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1016\/j.jsxm.2018.04.242","volume":"15","author":"U Milenkovic","year":"2018","unstructured":"Milenkovic U, Ilg MM, van Renterghem K, De Ridder D, Albersen M. 277 Interplay between TNFa and TGF-B1 in a cell culture model of Peyronie\u2019s Disease. J Sex Med. 2018;15:S234\u2013S234.","journal-title":"J Sex Med"},{"key":"845_CR67","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1016\/S2665-9913(22)00093-5","volume":"4","author":"J Nanchahal","year":"2022","unstructured":"Nanchahal J, Ball C, Rombach I, Williams L, Kenealy N, Dakin H, et al. Anti-tumour necrosis factor therapy for early-stage Dupuytren\u2019s disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 2022;4:e407\u201316.","journal-title":"Lancet Rheumatol"},{"key":"845_CR68","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc1387","volume":"4","author":"MN Pollak","year":"2004","unstructured":"Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004;4:505\u201318.","journal-title":"Nat Rev Cancer"},{"key":"845_CR69","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/jsm.12760","volume":"12","author":"RA Gelfand","year":"2015","unstructured":"Gelfand RA, Vernet D, Kovanecz I, Rajfer J, Gonzalez\u2010Cadavid NF. The transcriptional signatures of cells from the human Peyronie\u2019s disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets. J Sex Med. 2015;12:313\u201327.","journal-title":"J Sex Med"},{"key":"845_CR70","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1096\/fj.201901719RRqiyu","volume":"34","author":"DM Hernandez","year":"2020","unstructured":"Hernandez DM, Kang JH, Choudhury M, et al. IPF pathogenesis is dependent upon TGF\u03b2 induction of IGF-1. FASEB J. 2020;34:5363\u201388. https:\/\/doi.org\/10.1096\/fj.201901719RRqiyu.","journal-title":"FASEB J"},{"key":"845_CR71","doi-asserted-by":"crossref","unstructured":"Borthwick, LA. The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. In Seminars in immunopathology. Springer Berlin Heidelberg; 2016. p. 517\u201334.","DOI":"10.1007\/s00281-016-0559-z"},{"key":"845_CR72","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1172\/JCI12568","volume":"107","author":"M Kolb","year":"2001","unstructured":"Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J.Transient expression of IL-1\u03b2 induces acute lung injury and chronic repair leading to pulmonary fibrosis.J Clin Investig. 2001;107:1529\u201336.","journal-title":"J Clin Investig"},{"key":"845_CR73","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33:829\u201337.","journal-title":"Eur Heart J"},{"key":"845_CR74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrurol.2010.24","volume":"7","author":"NF Gonzalez-Cadavid","year":"2010","unstructured":"Gonzalez-Cadavid NF, Rajfer J. Treatment of Peyronie\u2019s disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol. 2010;7:215\u201321.","journal-title":"Nat Rev Urol"},{"key":"845_CR75","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1093\/ndt\/gfp103","volume":"24","author":"JE Toblli","year":"2009","unstructured":"Toblli JE, Ferrini MG, Cao G, Vernet D, Angerosa M, Gonzalez-Cadavid NF. Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus. Nephrol Dialysis Transplant. 2009;24:2384\u201391.","journal-title":"Nephrol Dialysis Transplant"},{"key":"845_CR76","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1513\/AnnalsATS.202110-1160ED","volume":"19","author":"YH Khor","year":"2022","unstructured":"Khor YH, Adegunsoye A. Inhaled nitric oxide for fibrotic interstitial lung disease: a step forward. Annal Am Thoracic Soc. 2022;19:536\u20138. https:\/\/doi.org\/10.1513\/AnnalsATS.202110-1160ED.","journal-title":"Annal Am Thoracic Soc"},{"key":"845_CR77","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/j.1939-4640.2001.tb02207.x","volume":"22","author":"TJ Bivalacqua","year":"2001","unstructured":"Bivalacqua TJ, Champion HC, Leungwattanakij S, Yang DY, Hyun JS, Abdel\u2010Mageed AB. et al. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie\u2019s\u2010like condition in the rat. J Androl. 2001;22:497\u2013506.","journal-title":"J Androl"},{"key":"845_CR78","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1111\/j.1743-6109.2010.01884.x","volume":"7","author":"MG Ferrini","year":"2010","unstructured":"Ferrini MG, Rivera S, Moon J, Vernet D, Rajfer J, Gonzalez-Cadavid NF. The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes. J Sex Med. 2010;7:3033\u201344. https:\/\/doi.org\/10.1111\/j.1743-6109.2010.01884.x.","journal-title":"J Sex Med"},{"key":"845_CR79","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/s1089-8603(02)00124-6","volume":"7","author":"D Vernet","year":"2002","unstructured":"Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J, et al. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie\u2019s fibrotic plaque and in its rat model. Nitric Oxide. 2002;7:262\u201376. https:\/\/doi.org\/10.1016\/s1089-8603(02)00124-6.","journal-title":"Nitric Oxide"},{"key":"845_CR80","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1095\/biolreprod.104.030833","volume":"71","author":"HH Davila","year":"2004","unstructured":"Davila HH, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie\u2019s disease. Biol Reprod. 2004;71:1568\u201377.","journal-title":"Biol Reprod"},{"key":"845_CR81","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/sj.ijir.3900556","volume":"12","author":"TJ Bivalacqua","year":"2000","unstructured":"Bivalacqua TJ, Champion HC, Mehta YS, et al. Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int J Impot Res. 2000;12:S8\u201317. https:\/\/doi.org\/10.1038\/sj.ijir.3900556.","journal-title":"Int J Impot Res"},{"key":"845_CR82","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, et al. FGF\/FGFR signaling in health and disease. Signal Transduct Targeted Ther. 2020;5:181.","journal-title":"Signal Transduct Targeted Ther"},{"key":"845_CR83","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","volume":"4","author":"DM Ornitz","year":"2015","unstructured":"Ornitz DM, Itoh N. The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev: Dev Biol. 2015;4:215\u201366.","journal-title":"Wiley Interdiscip Rev: Dev Biol"},{"key":"845_CR84","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nrm3528","volume":"14","author":"R Goetz","year":"2013","unstructured":"Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol. 2013;14:166\u201380.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"845_CR85","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2017.09.003","volume":"38","author":"DM Dolivo","year":"2017","unstructured":"Dolivo DM, Larson SA, Dominko T. Fibroblast growth factor 2 as an antifibrotic: antagonism of myofibroblast differentiation and suppression of pro-fibrotic gene expression. Cytokine Growth Factor Rev. 2017;38:49\u201358.","journal-title":"Cytokine Growth Factor Rev"},{"key":"845_CR86","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00005392-200102000-00016","volume":"165","author":"JP Mulhall","year":"2001","unstructured":"Mulhall JP, Thom J, Lubrano T, Shankey TV.Basic fibroblast growth factor expression in Peyronie\u2019s disease.J Urol. 2001;165:419\u201323.","journal-title":"J Urol"},{"key":"845_CR87","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/01.ju.0000070860.78370.08","volume":"170","author":"JP Mulhall","year":"2003","unstructured":"Mulhall JP, Branch J, Lubrano T, Shankey TV.Radiation increases fibrogenic cytokine expression by Peyronie\u2019s disease fibroblasts.J Urol. 2003;170:281\u20134.","journal-title":"J Urol"},{"key":"845_CR88","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ijir.2011.36","volume":"23","author":"E Chung","year":"2011","unstructured":"Chung E, De Young L, Brock GB. Rat as an animal model for Peyronie\u2019s disease research: a review of current methods and the peer-reviewed literature. Int J Impot Res. 2011;23:235\u201341.","journal-title":"Int J Impot Res"},{"key":"845_CR89","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.urology.2009.03.017","volume":"74","author":"I Stancik","year":"2009","unstructured":"Stancik I, Sch\u00e4fer R, Andrukhova O, Oeser R, Plas E, Pfl\u00fcger H. Effect of transdermal electromotive drug therapy on fibrogenic cytokine expression in Peyronie\u2019s disease. Urology. 2009;74:566\u201370.","journal-title":"Urology"},{"key":"845_CR90","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.matbio.2018.03.017","volume":"68-69","author":"O Burgy","year":"2018","unstructured":"Burgy O, K\u00f6nigshoff M. The WNT signaling pathways in wound healing and fibrosis. Matrix Biol. 2018;68-69:67\u201380. https:\/\/doi.org\/10.1016\/j.matbio.2018.03.017.","journal-title":"Matrix Biol"},{"key":"845_CR91","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/j.1743-6109.2012.02704.x","volume":"9","author":"GH Dolmans","year":"2012","unstructured":"Dolmans GH, Werker PM, de Jong IJ, Nijman RJ, LifeLines Cohort Study, Wijmenga C, Ophoff RA. WNT2 locus is involved in genetic susceptibility of Peyronie\u2019s disease. J Sex Med. 2012;9:1430\u20134.","journal-title":"J Sex Med"},{"key":"845_CR92","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/13685538.2019.1643311","volume":"23","author":"EJP Ten Dam","year":"2020","unstructured":"Ten Dam EJP, van Driel MF, de Jong IJ, Werker PM, Bank RA. Glimpses into the molecular pathogenesis of Peyronie\u2019s disease. Aging Male. 2020;23:962\u201370.","journal-title":"Aging Male"},{"key":"845_CR93","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1743-6109.2009.01556.x","volume":"7","author":"LX De Young","year":"2010","unstructured":"De Young LX, Bella AJ, O\u2019Gorman DB, Gan BS, Lim KB, Brock GB.Protein biomarker analysis of primary Peyronie\u2019s disease cells.J Sex Med. 2010;7:99\u2013106.","journal-title":"J Sex Med"},{"key":"845_CR94","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41443-019-0113-3","volume":"31","author":"T Liu","year":"2019","unstructured":"Liu T, Shindel AW, Lin G, Lue TF. Cellular signaling pathways modulated by low-intensity extracorporeal shock wave therapy. Int J Impot Res. 2019;31:170\u20136.","journal-title":"Int J Impot Res"},{"key":"845_CR95","doi-asserted-by":"publisher","unstructured":"Gundogdu G, Nguyen T, Namasivayam A, Starek S, Gelman J, Mauney, JR. Characterization of a novel rabbit model of Peyronie\u2019s disease. Int J Impot Res. 2023. https:\/\/doi.org\/10.1038\/s41443-023-00671-y.","DOI":"10.1038\/s41443-023-00671-y"},{"key":"845_CR96","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0022-5347(18)35214-5","volume":"173","author":"TX Minor","year":"2005","unstructured":"Minor TX, Lin G, Jad A, Lin CS, Hayashi N, F. Lue T. 1058: the effect of pentoxifylline on cultured human tunical fibroblasts from patients with Peyronie\u2019s Disease. J Urol. 2005;173:287\u2013287.","journal-title":"J Urol"},{"key":"845_CR97","doi-asserted-by":"publisher","first-page":"e1144","DOI":"10.1016\/j.juro.2016.02.2481","volume":"195","author":"J Campbell","year":"2016","unstructured":"Campbell J, DeYoung L, Chung E, Brock G. Mp89-20 traction applied to peyronie\u2019s disease cells reduces cellular fibrosis. J Urol. 2016;195:e1144.","journal-title":"J Urol"},{"key":"845_CR98","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11655-019-3203-7","volume":"25","author":"Q Geng","year":"2019","unstructured":"Geng Q, Wang F, Han Q, Chen SF, Ouyang B, Li Z, et al. Antioxidant mechanism of Xiaojin Pill (\u5c0f\u91d1\u4e38) for treatment of Peyronie\u2019s disease in rats based on matrix metalloproteinases. Chin J Integr Med. 2019;25:671\u20136.","journal-title":"Chin J Integr Med"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00845-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00845-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00845-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T10:02:32Z","timestamp":1733479352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00845-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":98,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1038\/s41443-024-00845-2","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}